Armistice Capital »

Abbott Laboratories shares owned by Armistice Capital

Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Abbott Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Abbott Laboratories held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbott Laboratories by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 22k 90.74

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Abbott Laboratories

BlackRock
Vanguard Capital Management
State Street Corporation
Charles Schwab Investment Management
Sixth Street Partners Management Company
Vanguard Portfolio Management
Geode Capital Management
Capital Research Global Investors
Capital Research and Management Company - Division 3
Morgan Stanley
Norges Bank Investment Management
Franklin Resources
Goldman Sachs Group
Northern Trust
Bank of America Corporation

View all funds holding Abbott Laboratories